¼¼°èÀÇ ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ ¼Ò¸ðǰ ½ÃÀå
Polymerase Chain Reaction Consumables
»óǰÄÚµå : 1571869
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 179 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,053,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ ¼Ò¸ðǰ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 6¾ï 690¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 4¾ï 8,320¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ ¼Ò¸ðǰ ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ 2023-2030³â¿¡ CAGR 3.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 6¾ï 690¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®µÈ ºÎ¹® Áß ÇϳªÀÎ PCR Æ©ºê´Â CAGR 4.0%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§ 2¾ï 5,050¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. PCR ¸¶ÀÌÅ©·ÎÇ÷¹ÀÌÆ® ºÐ¾ßÀÇ ¼ºÀåÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 2,650¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ ¼Ò¸ðǰ ½ÃÀåÀº 2023³â 1¾ï 2,650¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ 2023-2030³â CAGRÀ» 5.9%·Î 2030³â±îÁö 1¾ï 3,450¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 0.8%¿Í 2.4%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR) ¼Ò¸ðǰ ½ÃÀå- ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

PCR ¼Ò¸ðǰ ½ÃÀåÀÌ ºÐÀÚ »ý¹°Çаú Áø´ÜÇп¡¼­ °¢±¤¹Þ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR) ¼Ò¸ðǰ ½ÃÀåÀº DNA ÁõÆø°ú ºÐ¼®ÀÇ Á¤È®Çϰí È¿À²ÀûÀÎ ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ºÐÀÚ »ý¹°Çаú Áø´ÜÇп¡¼­ °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. PCR ±â¼úÀº À¯ÀüÀÚ ¿¬±¸, °¨¿° Áø´Ü, ¹ýÀÇÇÐ ºÐ¼®À» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡¼­ ÇʼöÀûÀÎ µµ±¸°¡ µÇ¾ú½À´Ï´Ù. ƯÁ¤ DNA ¼­¿­À» ³ôÀº °¨µµ¿Í ƯÀ̼ºÀ¸·Î ÁõÆø½ÃŰ´Â PCRÀÇ ´É·ÂÀº ¼¼°è ½ÇÇè½Ç¿¡¼­ ±âº»ÀûÀÎ ±â¼úÀÌ µÇ°í ÀÖ½À´Ï´Ù. À¯ÀüüÇÐ, ¸ÂÃãÇü ÀÇ·á, ºÐÀÚÁø´Ü¿¡ ´ëÇÑ °ü½É Áõ°¡´Â ¿¬±¸ÀÚ¿Í °Ç°­ °ü¸® Á¦°ø¾÷ü°¡ ºÐ¼® ´É·ÂÀ» °­È­ÇÏ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â µµ±¸¸¦ ã°í Àֱ⠶§¹®¿¡ PCR ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

PCR ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â °¨¿°ÀÇ À¯Çà°ú ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü ¼Ö·ç¼ÇÀÇ Çʿ伺 Áõ°¡ÀÔ´Ï´Ù. COVID-19ÀÇ ´ëÀ¯ÇàÀº °¨¿°ÀÇ È®Àΰú °ü¸®¿¡¼­ PCR °Ë»çÀÇ Áß¿äÇÑ ¿ªÇÒÀ» ºÎ°¢½Ã۰í, ½Ã¾à, ÇÁ¶óÀ̸Ó, ºÐ¼® ŰƮ µîÀÇ PCR ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ°Ô µÇ¾ú½À´Ï´Ù. Á¤ºÎ¿Í ÀÇ·á±â°üÀÌ °øÁߺ¸°Ç°ú Áúº´°¨½Ã¸¦ ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥ ½Å¼Ó°Ë»ç¸¦ À§ÇÑ PCR±â¼úÀÇ Ã¤¿ëÀº ¾ÕÀ¸·Îµµ °è¼ÓµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃßÁøÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ¶ÇÇÑ, ¹Ì»ý¹°ÇÐ ¹× ¹ÙÀÌ·¯½ºÇÐ ¿¬±¸°³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÁÖ·ÂÀº ÀÓ»ó ¹× ¿¬±¸ ȯ°æ¿¡¼­ PCR ¼Ò¸ðǰ ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

±â¼úÀÇ ¹ßÀü°ú Çõ½ÅÀº PCR ¼Ò¸ðǰ ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϴ°¡?

±â¼úÀÇ Áøº¸¿Í Çõ½ÅÀº Á¦Ç° ¼º´É Çâ»ó, ÀÀ¿ë ºÐ¾ß È®´ë, »ç¿ëÀÚ ÆíÀǼº Çâ»óÀ¸·Î PCR ¼Ò¸ðǰ ½ÃÀåÀ» Å©°Ô Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ÁÖ¸ñÇÒ¸¸ÇÑ °³¹ß Áß Çϳª´Â DNA ÁõÆøÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â ÇÏÀÌÇǵ¨¸®Æ¼ DNA ÁßÇÕÈ¿¼ÒÀÇ µµÀÔÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °í±Þ È¿¼Ò´Â ÁõÆø °úÁ¤¿¡¼­ ¿À·ùÀÇ ¿À¿°À» ÃÖ¼ÒÈ­ÇÏ°í º¸´Ù °íǰÁúÀÇ DNA Á¦Ç°À» Á¦°øÇÕ´Ï´Ù. ³ôÀº 󸮷® ½ÃÄö½Ì ¹× Á¤·® PCR(qPCR)°ú °°Àº ƯÁ¤ ¿ëµµ¸¦ À§ÇØ ¼³°èµÈ Ư¼ö Æú¸®¸Ó¶óÁ¦¸¦ »ç¿ëÇÒ ¼ö ÀÖ°Ô µÊÀ¸·Î½á ½ÇÇè½Ç ¹× ÀÓ»ó ½ÇÇè½Ç¿¡¼­ PCR ¼Ò¸ðǰÀÇ ¹ü¿ë¼º°ú ¸Å·Â Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

PCR ¿öÅ©Ç÷οìÀÇ ÀÚµ¿È­¿Í µðÁöÅÐ ±â¼úÀÇ ÅëÇÕÀº ¼Ò¸ðǰ ½ÃÀåÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. »ùÇà Áغñ, PCR ¼³Á¤ ¹× ºÐ¼®À» À§ÇÑ ÀÚµ¿È­ ½Ã½ºÅÛÀº °øÁ¤À» °£¼ÒÈ­Çϰí ÈÞ¸Õ ¿À·ùÀÇ °¡´É¼ºÀ» ÁÙÀÔ´Ï´Ù. ÀÌ ÀÚµ¿È­·ÎÀÇ ÀüȯÀº ´ë·®ÀÇ »ùÇÃÀ» ºü¸£°í È¿À²ÀûÀ¸·Î ó¸®ÇØ¾ß ÇÏ´Â ³ôÀº 󸮷® ½ÇÇè½Ç¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ÇÁ¸®ÇÊµå ¹ÝÀÀ Ç÷¹ÀÌÆ®¿Í Áï½Ã »ç¿ëÇÒ ¼ö ÀÖ´Â ½Ã¾à ŰƮ µî ÀÚµ¿È­ Ç÷§Æû°ú ȣȯµÇ´Â ¼Ò¸ðǰÀÇ °³¹ßÀº ´Ù¾çÇÑ Àå¸é¿¡¼­ PCR ±â¼úÀÇ Ã¤¿ëÀ» ÃËÁøÇÏ¿© Àü¹ÝÀûÀÎ È¿À²°ú »ý»ê¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ½Ç½Ã°£ PCR°ú Á¤·® PCR¿¡ ´ëÇÑ °ü½É Áõ°¡°¡ PCR ¼Ò¸ðǰ ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ½Ç½Ã°£ PCR ±â¼úÀº ÁõÆø °úÁ¤À» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇϰí DNA ¹× RNA Ÿ°ÙÀÇ Á¤·® ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. À¯ÀüÀÚ ¹ßÇö ºÐ¼®, º´¿øÃ¼ °ËÃâ, À¯ÀüÀÚ º¯ÀÌ ¿¬±¸ µîÀÇ ¿ëµµ·Î Á¤È®ÇÑ Á¤·®È­¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, Çü±¤ »ö¼Ò³ª ÇÁ·Îºê¸¦ Æ÷ÇÔÇÑ Æ¯¼öÇÑ ¼Ò¸ðǰ¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ÜÀÏ ¹ÝÀÀÀ¸·Î ¿©·¯ ´ë»óÀ» µ¿½Ã¿¡ °¨ÁöÇÒ ¼ö ÀÖ´Â ¸ÖƼÇ÷º½º PCRÀÇ Áøº¸µµ Áø´Ü °Ë»ç ¹× ¿¬±¸ ÀÀ¿ëÀÇ È¿À²¼ºÀ» ³ô¿© ½ÃÀåÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Æ÷ÀÎÆ® ¿Àºê Äɾî(POC) °Ë»ç¿Í ºÐ»ê Áø´ÜÀÇ »ó½ÂÀº PCR ¼Ò¸ðǰ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ½ÇÇè½Ç À̿ܿ¡¼­ ½Ç½Ã °¡´ÉÇÑ ½Å¼ÓÇϰí ÈÞ´ë¿ë °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦Á¶¾÷ü °¢ ȸ»ç´Â ÄÄÆÑÆ®ÇÑ Àåºñ, °£¼ÒÈ­µÈ ½Ã¾à, »ç¿ëÀÚ Ä£È­ÀûÀÎ ºÐ¼® ŰƮ µî POC ¿ëµµ¿ëÀ¸·Î Ưº°È÷ ¼³°èµÈ PCR ¼Ò¸ðǰÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ȯÀÚÀÇ Áø·á ÇöÀå¿¡¼­ PCR °Ë»ç¸¦ ¼öÇàÇÒ ¼ö ÀÖÀ¸¸ç Àû½Ã¿¡ Áø´Ü ¹× Ä¡·á¸¦ ÅëÇØ ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. POC °Ë»ç°¡ °è¼Ó º¸±ÞµÊ¿¡ µû¶ó ÀÌ ½ÃÀå ºÎ¹®¿¡ ¸Â´Â PCR ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇаú ±ÔÁ¦ µ¿ÇâÀº PCR ¼Ò¸ðǰ ä¿ëÀ» Çü¼ºÇÏ´Â µ¥ ¾î¶² ¿ªÇÒÀ» Çմϱî?

½ÃÀå ¿ªÇаú ±ÔÁ¦ µ¿ÇâÀº Á¤È®¼º, È¿À²¼º ¹× ÄÄÇöóÀ̾𽺿¡ ´ëÇÑ ¿ä±¸ÀÇ º¯È­¿¡ ¾÷°è°¡ ´ëÀÀÇÏ´Â °¡¿îµ¥ PCR ¼Ò¸ðǰÀÇ Ã¤¿ëÀ» Çü¼ºÇϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÓ»ó ÇöÀå¿¡¼­ ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´ÜÀÇ Á߿伺 Áõ°¡´Â PCR ¼Ò¸ðǰ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ȯÀÚÀÇ Ä¡·á¸¦ °­È­ÇÏ°í °¨¿°À» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ ³ë·ÂÇÏ´Â µ¿¾È PCR ±â¼úÀ» äÅÃÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. ºü¸£°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ Á¦°øÇÏ´Â PCRÀÇ ´É·ÂÀº ÀÏ»ó Áø´Ü ¿öÅ©Ç÷ο쿡 PCR ¼Ò¸ðǰÀ» ÅëÇÕÇÏ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù.

Áø´Ü °Ë»ç¿Í ǰÁú º¸ÁõÀ» µÑ·¯½Ñ ±ÔÁ¦ ¾Ð·Âµµ PCR ¼Ò¸ðǰÀÇ Ã¤¿ë¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA) ¹× À¯·´ÀǾàû(EMA)°ú °°Àº ±ÔÁ¦±â°üÀº PCR ºÐ¼® ¹× ¼Ò¸ðǰÀ» Æ÷ÇÔÇÑ Áø´Ü Á¦Ç°ÀÇ ½ÂÀÎ ¹× ǰÁú °ü¸®¿¡ ´ëÇÑ ¾ö°ÝÇÑ ÁöħÀ» ¸¶·ÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¤À» ÁؼöÇÏ´Â °ÍÀº Á¦Ç°ÀÇ ¾ÈÀü°ú È¿°ú¸¦ º¸ÀåÇÏ·Á´Â Á¦Á¶¾÷ü¿¡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °Ë»ç½Ç¹«¿¡¼­ÀÇ Ç°Áúº¸Áõ°ú Ç¥ÁØÈ­¿¡ ´ëÇÑ ÁÖ¸ñ Áõ°¡´Â ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·ÇÏ°í ¾ÈÁ¤ÀûÀÎ ¼º´ÉÀ» Á¦°øÇÏ´Â PCR ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÐÀÚÁø´Ü ¾÷°è ³» °æÀï ±¸µµµµ PCR ¼Ò¸ðǰÀÇ Ã¤¿ëÀ» Çü¼ºÇÏ´Â Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ¼ö¸¹Àº Á¦Á¶¾÷üµéÀÌ Çõ½ÅÀûÀÎ Á¦Ç°°ú °æÀï°¡°ÝÀ» ¹«±â·Î ½ÃÀå¿¡ ÁøÃâÇϰí ÀÖÀ¸¸ç, ¼ÒºñÀڵ鿡°Ô °¡¿ë¼º°ú ¼±Åà Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ °æÀïÀº Á¦Ç° °³¹ßÀÇ Áøº¸¸¦ ÃËÁøÇÏ°í ¿¬±¸ÀÚ¿Í ÀÓ»óÀÇÀÇ Æ¯Á¤ ¿ä±¸¿¡ ºÎÀÀÇÏ´Â °íǰÁú PCR ¼Ò¸ðǰÀÇ ¼Ò°³¸¦ °¡´ÉÇϰÔÇÕ´Ï´Ù. Á¦Ç° Â÷º°È­¿Í °í°´ Áö¿ø¿¡ ´ëÇÑ ÁÖ·ÂÀº PCR ¼Ò¸ðǰ ½ÃÀå¿¡¼­ÀÇ Á¸Àç°¨À» ³ôÀÌ°í ±× º¸±Þ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

°íǰÁú, ½Å·Ú¼º, »ç¿ëÇϱ⠽¬¿î Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ PCR ¼Ò¸ðǰÀÇ Ã¤Åÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. °Ë»ç½Ç°ú ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ °Ë»ç ´É·ÂÀ» °­È­ÇϰíÀÚ ÇÏ´Â µ¿¾È »ç¿ë ÆíÀǼº, ÀçÇö¼º ¹× °ß°í¼ºÀ» °®Ãá ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦Á¶¾÷ü °¢»ç´Â Áï½Ã »ç¿ëÇÒ ¼ö Àִ ŰƮ, ÃÖÀûÈ­µÈ ½Ã¾à, PCR ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ´Â Á¾ÇÕÀûÀÎ ºÐ¼® ÇÁ·ÎÅäÄÝÀ» °³¹ßÇÔÀ¸·Î½á ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. Á¤È®Çϰí È¿À²ÀûÀÎ °Ë»ç¸¦ °¡¼ÓÈ­ÇÏ´Â °íǰÁú ¼Ò¸ðǰÀ» Á¦°øÇÏ´Â ´É·ÂÀº ½ÃÀå¿¡¼­ °æÀï ¿ìÀ§¸¦ Â÷ÁöÇÏ·Á´Â Á¦Á¶¾÷ü¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù.

¼¼°è PCR ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº?

¼¼°è PCR ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀº Á¤È®ÇÏ°í ½Å¼ÓÇÑ Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, °¨¿°ÀÇ À¯Çà Áõ°¡, ºÐÀÚ »ý¹°ÇÐ ¿¬±¸ÀÇ Áö¼ÓÀûÀÎ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ´Ù¾çÇÑ °Ç°­ °ü¸® ȯ°æ¿¡¼­ ºü¸£°í ¾ÈÁ¤ÀûÀÎ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ °¨¿°ÀÇ Àû½Ã Áø´Ü ¹× Ä¡·á¸¦ ¼±È£ÇÏ´Â µ¿¾È PCR ±â¼úÀ» äÅÃÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. ½Ã¾à, ÇÁ¶óÀ̸Ó, ºÐ¼® ŰƮ µîÀÇ °íǰÁú PCR ¼Ò¸ðǰÀÇ ¿ä±¸µµ º´·Ä·Î Áõ°¡Çϰí ÀÖÀ¸¸ç ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

°¨¿°ÀÇ À¯Çà, ƯÈ÷ COVID-19ÀÇ À¯Çà(¼¼°èÀû À¯Çà)Àº ½ÃÀå ¼ºÀåÀÇ ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀ̵Ǿú½À´Ï´Ù. À¯ÇິÀº °¨¿°ÀÇ È®»êÀ» ¾ïÁ¦Çϱâ À§ÇÑ PCR °Ë»çÀÇ Á߿伺À» °­Á¶Çϰí, PCR ¼Ò¸ðǰÀÇ »ó´çÇÑ ¼ö¿ä ±ÞÁõÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. Á¤ºÎ³ª ÀÇ·á±â°üÀÌ °Ë»ç ÀÎÇÁ¶ó¿Í °Ë»ç ´É·Â¿¡ ÅõÀÚÇÏ´Â °¡¿îµ¥ °íǰÁú PCR ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä´Â ¾ÕÀ¸·Îµµ ³ô¾ÆÁö°í ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÐÀÚ »ý¹°ÇÐ ¿¬±¸¿Í ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀº PCR ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇÕ´Ï´Ù. À¯ÀüÀÚ ¹ßÇö ºÐ¼®, À¯ÀüÀÚÇü ÆÇÁ¤, ȯ°æ °Ë»ç µî PCRÀÇ »õ·Î¿î ¾ÖÇø®ÄÉÀ̼ÇÀÇ °³¹ßÀº ÀÌ·¯ÇÑ ¿ä±¸¿¡ ¸Â´Â Ư¼ö ¼Ò¸ðǰ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸ÖƼÇ÷º½Ì ¹× µðÁöÅÐ PCR°ú °°Àº PCR ±â¼úÀÇ Çõ½ÅÀº ¿ëµµÀÇ ÆøÀ» ³ÐÈ÷°í °Ë»çÀÇ °¨µµ¿Í ƯÀ̼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ¿¬±¸ÀÚ°¡ À¯ÀüüÇÐ¿Í Áø´Ü¿¡¼­ »õ·Î¿î ÇÁ·ÐƼ¾î¸¦ ޱ¸ÇÔ¿¡ µû¶ó °í¼º´É PCR ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

°Ô´Ù°¡ POC(Point of Care) °Ë»ç¿Í ºÐ»ê Áø´Ü¿¡ ´ëÇÑ °ü½É Áõ°¡´Â PCR ¼Ò¸ðǰ ½ÃÀå¿¡ »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ Áø·á ÇöÀå¿¡¼­ ½Ç½Ã °¡´ÉÇÑ ½Å¼ÓÇϰí ÈÞ´ë¿ë °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦Á¶¾÷ü´Â POC ¿ëµµ¿ëÀ¸·Î Ưº°È÷ ¼³°èµÈ PCR ¼Ò¸ðǰÀ» °³¹ßÇÏ¿© ÀÓ»ó ÇöÀå¿¡¼­ PCR ±â¼úÀÇ Á¢±Ù¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÀÇ·á Á¦°ø¾÷ü°¡ È¿À²ÀûÀ̰í È¿°úÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀÇ µµÀÔÀ» ¿ä±¸ÇÏ´Â µ¿¾È PCR ¼Ò¸ðǰÀÇ Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ÀÚµ¿È­ ¹× µ¥ÀÌÅÍ ºÐ¼®¿¡ À־ÀÇ ±â¼ú Áøº¸ÀÇ ¿µÇâÀÌ PCR ¼Ò¸ðǰ ½ÃÀåÀ» ÀçÇü¼ºÇϰí ÀÖ½À´Ï´Ù. ½ÇÇè½Ç ¿öÅ©Ç÷ο쿡¼­ ÀÚµ¿È­ ½Ã½ºÅÛ°ú µðÁöÅÐ ÅøÀÇ ÅëÇÕÀº PCR °Ë»çÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. »ùÇà Áغñ, PCR ¼³Á¤ ¹× µ¥ÀÌÅÍ ºÐ¼®¿¡¼­ ÀÚµ¿È­ äÅà Áõ°¡´Â ÀÌ·¯ÇÑ ½Ã½ºÅÛ°ú ȣȯµÇ´Â ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÇÇè½Ç¿¡¼­´Â 󸮷®À» Çâ»ó½Ã۰í ÀÎÀû ½Ç¼ö¸¦ ÁÙÀ̱â À§ÇØ ÀÚµ¿È­¿¡ ´ëÇÑ ÅõÀÚ°¡ Á¡Á¡ ´Ã¾î³ª°í ÀÖÀ¸¸ç, ÀÚµ¿È­ ¿öÅ©Ç÷ο쿡 ¸Â´Â °íǰÁú PCR ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ·¯ÇÑ ¿äÀεéÀÌ ¼ö·ÅÇÔ¿¡ µû¶ó ¼¼°è PCR ¼Ò¸ðǰ ½ÃÀåÀº ±â¼ú ¹ßÀü, ¿ëµµ È®´ë, ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´ÜÀÇ Á߿伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó °­·ÂÇÏ°Ô ¼ºÀåÇÒ ¼ö Àִ ż¼¸¦ °®°í ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(Àü 11»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Polymerase Chain Reaction Consumables Market to Reach US$606.9 Million by 2030

The global market for Polymerase Chain Reaction Consumables estimated at US$483.2 Million in the year 2023, is expected to reach US$606.9 Million by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. PCR Tubes, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$250.5 Million by the end of the analysis period. Growth in the PCR Microplates segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$126.5 Million While China is Forecast to Grow at 5.9% CAGR

The Polymerase Chain Reaction Consumables market in the U.S. is estimated at US$126.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$134.5 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Polymerase Chain Reaction (PCR) Consumables Market - Key Trends & Drivers Summarized

Why Is the PCR Consumables Market Gaining Prominence in Molecular Biology and Diagnostics?

The polymerase chain reaction (PCR) consumables market is gaining prominence in molecular biology and diagnostics due to the increasing demand for accurate and efficient methods of DNA amplification and analysis. PCR technology has become an indispensable tool in various applications, including genetic research, infectious disease diagnostics, and forensic analysis. The ability of PCR to amplify specific DNA sequences with high sensitivity and specificity makes it a fundamental technique in laboratories worldwide. The rising interest in genomics, personalized medicine, and molecular diagnostics is driving the growth of the PCR consumables market, as researchers and healthcare providers seek reliable tools to enhance their analytical capabilities.

One of the primary factors contributing to the growth of the PCR consumables market is the increasing prevalence of infectious diseases and the need for rapid and accurate diagnostic solutions. The COVID-19 pandemic has highlighted the critical role of PCR testing in identifying and managing infectious diseases, leading to a surge in demand for PCR consumables such as reagents, primers, and assay kits. As governments and healthcare organizations prioritize public health and disease surveillance, the adoption of PCR technology for rapid testing is expected to continue, further driving the growth of the consumables market. Additionally, the ongoing focus on research and development in microbiology and virology is likely to increase the demand for PCR consumables in clinical and research settings.

How Are Technological Advancements and Innovations Shaping the PCR Consumables Market?

Technological advancements and innovations are significantly shaping the PCR consumables market by improving product performance, expanding application areas, and enhancing user convenience. One notable development is the introduction of high-fidelity DNA polymerases that offer improved accuracy and efficiency in DNA amplification. These advanced enzymes minimize the incorporation of errors during the amplification process, resulting in higher-quality DNA products. The availability of specialized polymerases designed for specific applications, such as high-throughput sequencing or quantitative PCR (qPCR), is enhancing the versatility and appeal of PCR consumables in research and clinical laboratories.

The integration of automation and digital technologies in PCR workflows is also transforming the consumables market. Automated systems for sample preparation, PCR setup, and analysis streamline the process and reduce the potential for human error. This shift towards automation is particularly relevant in high-throughput laboratories, where large volumes of samples need to be processed quickly and efficiently. The development of consumables compatible with automated platforms, such as pre-filled reaction plates and ready-to-use reagent kits, is driving the adoption of PCR technology in various settings, increasing overall efficiency and productivity.

Furthermore, the increasing focus on real-time PCR and quantitative PCR is shaping the market for PCR consumables. Real-time PCR technology enables the monitoring of the amplification process in real time, allowing for quantitative analysis of DNA and RNA targets. The growing demand for accurate quantification in applications such as gene expression analysis, pathogen detection, and genetic variation studies is driving the need for specialized consumables, including fluorescent dyes and probes. The advancement of multiplex PCR, which allows for the simultaneous detection of multiple targets in a single reaction, is also expanding the market by increasing the efficiency of diagnostic testing and research applications.

Additionally, the rise of point-of-care (POC) testing and decentralized diagnostics is influencing the PCR consumables market. The demand for rapid and portable testing solutions that can be performed outside traditional laboratory settings is increasing. Manufacturers are developing PCR consumables specifically designed for POC applications, such as compact devices, simplified reagents, and user-friendly assay kits. These innovations enable healthcare providers to perform PCR testing at the site of patient care, improving patient outcomes through timely diagnosis and treatment. As POC testing continues to gain traction, the demand for PCR consumables tailored for this market segment is expected to grow.

What Role Do Market Dynamics and Regulatory Trends Play in Shaping the Adoption of PCR Consumables?

Market dynamics and regulatory trends play a crucial role in shaping the adoption of PCR consumables as industries respond to changing demands for accuracy, efficiency, and compliance. The increasing emphasis on rapid and accurate diagnostics in clinical settings is a key driver of the PCR consumables market. As healthcare providers strive to enhance patient care and manage infectious diseases effectively, the adoption of PCR technology becomes essential. The ability of PCR to deliver quick and reliable results is encouraging the integration of PCR consumables into routine diagnostic workflows, driving market growth.

Regulatory pressures surrounding diagnostic testing and quality assurance are also influencing the adoption of PCR consumables. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established stringent guidelines for the approval and quality control of diagnostic products, including PCR assays and consumables. Compliance with these regulations is critical for manufacturers seeking to ensure the safety and efficacy of their products. The increasing focus on quality assurance and standardization in laboratory practices is driving demand for PCR consumables that meet regulatory requirements and offer consistent performance.

The competitive landscape within the molecular diagnostics industry is another significant factor shaping the adoption of PCR consumables. Numerous manufacturers are entering the market with innovative products and competitive pricing, leading to increased availability and choice for consumers. This competition is driving advancements in product development, enabling the introduction of high-quality PCR consumables that cater to the specific needs of researchers and clinicians. The focus on product differentiation and customer support is enhancing the market presence of PCR consumables, contributing to their widespread adoption.

Consumer preferences for high-quality, reliable, and user-friendly products are also influencing the adoption of PCR consumables. As laboratories and healthcare providers seek to enhance their testing capabilities, there is a growing demand for consumables that offer ease of use, reproducibility, and robustness. Manufacturers are responding by developing ready-to-use kits, pre-optimized reagents, and comprehensive assay protocols that simplify the PCR process. The ability to provide high-quality consumables that facilitate accurate and efficient testing is essential for manufacturers looking to gain a competitive edge in the market.

What Factors Are Driving the Growth of the Global PCR Consumables Market?

The growth in the global PCR consumables market is driven by several factors, including the rising demand for accurate and rapid diagnostics, the increasing prevalence of infectious diseases, and ongoing advancements in molecular biology research. One of the primary growth drivers is the increasing demand for rapid and reliable diagnostic solutions across various healthcare settings. As healthcare providers prioritize timely diagnosis and treatment of infectious diseases, the adoption of PCR technology is becoming essential. The need for high-quality PCR consumables, such as reagents, primers, and assay kits, is rising in parallel, contributing to market growth.

The increasing prevalence of infectious diseases, particularly in light of the COVID-19 pandemic, is another key factor contributing to market growth. The pandemic has underscored the importance of PCR testing in controlling the spread of infectious diseases and has led to a significant surge in demand for PCR consumables. As governments and health organizations invest in testing infrastructure and capabilities, the demand for high-quality PCR consumables is expected to continue to rise, supporting the expansion of the market.

Ongoing advancements in molecular biology research and technology are also supporting the growth of the PCR consumables market. The development of new applications for PCR, including gene expression analysis, genotyping, and environmental testing, is driving demand for specialized consumables tailored to these needs. Innovations in PCR technology, such as multiplexing and digital PCR, are expanding the range of applications and enhancing the sensitivity and specificity of testing. As researchers explore new frontiers in genomics and diagnostics, the demand for high-performance PCR consumables is likely to grow.

Moreover, the increasing focus on point-of-care (POC) testing and decentralized diagnostics is creating new opportunities for the PCR consumables market. The demand for rapid and portable testing solutions that can be performed at the site of patient care is rising. Manufacturers are developing PCR consumables specifically designed for POC applications, enhancing the accessibility of PCR technology in clinical settings. This trend is expected to drive the adoption of PCR consumables as healthcare providers seek to implement efficient and effective diagnostic solutions.

Additionally, the impact of technological advancements in automation and data analysis is reshaping the PCR consumables market. The integration of automated systems and digital tools in laboratory workflows is enhancing efficiency and accuracy in PCR testing. The growing adoption of automation in sample preparation, PCR setup, and data analysis is driving demand for consumables that are compatible with these systems. As laboratories increasingly invest in automation to improve throughput and reduce human error, the demand for high-quality PCR consumables tailored for automated workflows is expected to increase.

As these factors converge, the global PCR consumables market is poised for robust growth, driven by technological advancements, expanding applications, and the increasing emphasis on rapid and accurate diagnostics across various sectors.

Select Competitors (Total 11 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â